# REGENTIS BIOMATERIALS LTD (RGNT)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/RGNT/

- Reporting holders: 6
- Reported value: $3.0M
- Shares held by institutions: 845,791 of 5,179,378 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Rosalind Advisors, Inc.](https://holderbook.com/funds/1622627-rosalind-advisors-inc/) | $2.5M | 701,685 | 0.9% | 3 |
| [Warberg Asset Management LLC](https://holderbook.com/funds/1597506-warberg-asset-management-llc/) | $306.2K | 86,980 | 0.1% | 1 |
| [JANE STREET GROUP, LLC](https://holderbook.com/funds/1595888-jane-street-group-llc/) | $153.0K | 43,333 | 0.0% | 1 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $47.1K | 13,348 | 0.0% | 1 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $1.5K | 434 | 0.0% | 2 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $39 | 11 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 6 | $3.0M |
| Q1 2026 | 3 | $1.7M |
| Q4 2025 | 3 | $1.9M |